Report Code: A12592 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Familial hypercholesterolemia is a hereditary disease caused because of increased levels of low-density lipoprotein (LDL) in the blood vessels. People suffering from familial hypercholesterolemia, are anticipated to be at a greater risk of developing cardiac disorders.
It is expected to expand the familial hypercholesterolemia treatment market in the coming years due to increase in diagnosis and treatment adoption rate. Hypercholesterolemia usually emerges from the grouping of environmental and genetic jeopardy factors. The genetic disorder leads to heterozygous familial hypercholesterolemia due to the presence of the mutated copy of the LDL receptor gene. The rise in adoption of combination therapy with the availability of high-level manufacturing technology has expanded the familial hypercholesterolemia treatment market.
COVID-19 Impact analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the familial hypercholesterolemia treatment market.
Top Impacting Factors
Market Trends
New product launches to flourish the market
In February 2020, Esperion Therapeutics Inc. declared that NEXLIZET, statin therapy received the U.S Food and Drug Administration (FDA) approval for heterozygous familial hypercholesterolemia treatment.
In January 2020, Novartis AG declared its acquisition of The Medicines Company through Medusa Merger Corporation. The objective of this acquisition was to expand the product portfolio in the familial hypercholesterolemia therapeutic drugs segment.
In October 2020, Novartis International AG received approval from the European Medicines Agency (EMA) for the marketing of the drug Leqvio (inclisiran). It is a potential drug that is used in the treatment of adults suffering from hypercholesterolemia or mixed dyslipidemia.
Key Benefits of the Report
Questions answered in the familial hypercholesterolemia treatment Report
Familial Hypercholesterolemia Treatment Market Report Highlights
Aspects | Details |
---|---|
By Indication Type |
|
By Drug |
|
By Route of Administration |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | Merck Company, Daiichi Sankyo Company Limited, Aegerion Pharmaceuticals, Sanofi S.A., Novartis AG, AstraZeneca Plc., Pfizer Inc., Amgen Inc., Esperion Therapeutics, AbbVie Inc. |
Loading Table Of Content...
Start reading.
This Report and over 71,296+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers